In Depth 15 Jan 2025
CRISPR: The gene editing tool changing the world (2025 update)
CRISPR-Cas9 has changed the world with the promise of making gene editing much easier and faster than before. But what is its real potential?
- Latest Posts
Best in Biotech 14 Jan 2025
Singapore’s biotech scene: 7 companies leading the way in 2025
Discover seven of the top biotech companies in Singapore – a country that set out to become a global biotech hub just over 20 years ago.
In Depth 13 Jan 2025
2025 predictions: Which trends are set to shape the biotech industry this year?
From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech industry in 2025.
News and Trends 10 Jan 2025
The in vivo revolution: How Interius, Umoja, and Vyriad are transforming CAR-T cell therapy
A U.S. trial of an in vivo CAR gene therapy has expanded to Europe, marking the first-ever trial of its kind in the region.
Podcast 10 Jan 2025
Fighting pain with non-opioid drugs
In the first episode of 2025, we talk about non-opioid pain drugs with Brixton Biosciences.
News and Trends 9 Jan 2025
Von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground
Explore advances in von Willebrand disease treatment, including Star Therapeutics’ VGA039, and other key players in the space.
ADVERTISEMENT
ADVERTISEMENT
In Depth 9 Jan 2025
Saudi Arabia: is the country set to become a global biotech hub?
In the last year or so, there have been a number of indications that Saudi Arabia is setting itself up to become a global biotech hub. Over the next decade, it is expected to become a world leader in biotech research and generate significant economic growth. The most recent indication of Saudi Arabia’s progress toward […]
Best in Biotech 8 Jan 2025
Ten drugs to watch in 2025: will these therapies become blockbusters?
Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate’s latest report.
In Depth 7 Jan 2025
The biggest private biotech investments in December 2024
The companies Nuvig Therapeutics, Ottimo Pharma, and Angitia Biopharmaceuticals bagged the biggest private biotech investments in December 2024.
Partnering 2030: Biopharma Report
Download Inpart’s latest report to hear from biotechs and out-licensors, following this year’s Partnering 2030 survey. The report includes real-world partnering experiences, challenges, and insights into working with top pharmaceutical firms.
Expert Advice 6 Jan 2025
What to look for in a biotech incubator
Building a biotech startup can be a daunting task and often founders rely on incubators – but how to choose the right one?
News and Trends 2 Jan 2025
A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development
Last month saw a number of alliances forming in a range of therapeutic spaces but there has been one serial collaborator that stands out – GSK.
ADVERTISEMENT
